Postmarketing reports of in-utero glatiramer acetate assessing pregnancy and foetal outcomes and breastfeeding practices
Latest Information Update: 23 Mar 2022
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 16 Mar 2022 Results published in the Drug Safety
- 16 Dec 2021 New trial record